A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment

This study investigated the efficiency and safety of imatinib in the lower dose (300 mg/d) in patients with gastrointestinal stromal tumor (GIST) who cannot tolerate imatinib in the standard dose (400 mg/d). Steady-state imatinib trough concentration (Cmin) values in 18 patients with GIST who were t...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Yin, Yuan, Xiang, Jin, Tang, Sumin, Chen, Jiaju, Yu, Qin, Zhang, Bo
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2016
Subjects:
4200
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266004/
https://ncbi.nlm.nih.gov/pubmed/27930532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005488
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items